<PAGE>
-----------------------------
| OMB APPROVAL |
-----------------------------
| OMB Number:3235-0145 |
| Expires: December 31, 1997 |
| Estimated average burden |
| hours per response...14.90 |
-----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
FUSION MEDICAL TECHNOLOGIES, INC.
- ------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock
- ------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
361128 10 1
- ------------------------------------------------------------------------------
(CUSIP NUMBER)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing of this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
SEC 1745 (2-95)
Page 1 of 5 Pages
<PAGE>
CUSIP NO. 361128 10 1 13G Page 2 of 5 Pages
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Philip M. Sawyer ###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES 455,675
BENEFICIALLY ---------------------------------------------------------
OWNED BY EACH 6 SHARED VOTING POWER
REPORTING PERSON
WITH 0
---------------------------------------------------------
7 SOLE DISPOSITIVE POWER
455,675
---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
455,675
- ------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.42%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE>
CUSIP NO. 361128 10 1 Page 3 of 5 Pages
ITEM 1.
(a) Name of Issuer: Fusion Medical Technologies, Inc.
(b) Address of Issuer's Principal Executive Offices:
1615 Plymouth Street
Mountain View, CA 94043
ITEM 2.
(a) Name of Person Filing: Philip M. Sawyer
(b) Address of Principal Business Office or, if none, Residence
1615 Plymouth Street
Mountain View, CA 94043
(c) Citizenship: United States of America
(d) Title of Class of Securities: Common Stock
(e) CUSIP Number: 361128 10 1
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b),
CHECK WHETHER THE PERSON IS A:
(a) / / Broker or Dealer registered under Section 15 of the Act
(b) / / Bank as defined in section 3(a)(6) of the Act
(c) / / Insurance Company as defined in section 3(a)(19) of the Act
(d) / / Investment Company registered under section 8 of the Investment
Company Act
(e) / / Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940
(f) / / Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund, see Section 240.13d-1(b)(1)(ii)(F)
(g) / / Parent Holding Company, in accordance with Section
240.13d-1(b)(ii)(G) (Note: See Item 7)
(h) / / Group, in accordance with Section 240.13d-1(b)(1)(ii)(H)
<PAGE>
CUSIP NO. 361128 10 1 Page 4 of 5 Pages
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned: 455,675
(b) Percent of Class: 6.42% (based on total outstanding shares at
12/31/97 of 7,098,892)
(c) Number of shares as to which such person has: 455,675
(i) sole power to vote or to direct the vote: 455,675
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or direct the disposition of: 455,675
(iv) shared power to dispose or direct the disposition of: 0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
that five percent of the class of securities, check the following / /
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Inapplicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Inapplicable.
Item 8. Identification and Classification of Members of the Group
Inapplicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Inapplicable.
<PAGE>
CUSIP NO. 361128 10 1 Page 5 of 5 Pages
ITEM 10.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course
of business and were not acquired for the purpose of and do not have the
effect of changing or influencing the control of the issuer of such
securities and were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
FEBRUARY 13, 1998
------------------------------------
Date
/s/ PHILIP M. SAWYER
------------------------------------
Signature
PHILIP M. SAWYER
------------------------------------
Name/Title
